Medical Device Defects, Voluntary Recalls and Medical Accidents
First written in FY2016. 13 of 17 entries say "Restated". Latest entry: FY2025-H1.
Japan Lifeline moved to the "Worse" side of this theme in 2023, the same year as the typical company in this theme.
The whole theme swung hardest in 2025: 13 of 35 companies on the "Worse" side.
49 other companies' latest entry also says "Restated".
- FY2025-H1RestatedAnnual report
「No new business or other risks arose during the current interim consolidated accounting period. In addition, there were no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The company disclosed that there had been no material changes regarding the risks of medical device defects, voluntary recalls and medical accidents. - FY2024-Q3MaterialisedAnnual report
「In particular, in the third quarter, a voluntary recall occurred involving an old model that was no longer being sold, while the number of cases requiring replacement of the pacemaker unit increased, which affected results.」
A voluntary recall occurred involving an old model whose sales had ended, and the resulting increase in pacemaker-unit replacement cases meant that defect and recall risks actually affected performance. - FY2023-Q3MaterialisedAnnual report
「The biliary stent tube sold since August of the same year continued to perform well, while certain points requiring improvement became apparent in some new products, and the company is working to resolve these issues.」
The company stated that points requiring improvement had become apparent in some new products in the gastroenterology field and that it was working to resolve the issues. - FY2021-Q2RestatedAnnual report
「No new business or other risks arose during the six-month period ended [the second quarter]. There were also no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The company disclosed that there had been no material changes regarding the risks of medical device defects, voluntary recalls and medical accidents. - FY2020-Q3RestatedAnnual report
「No new business or other risks arose during the cumulative third quarter of the current consolidated fiscal year. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The company disclosed that there had been no material changes regarding the risks of medical device defects, voluntary recalls and medical accidents. - FY2020-Q2RestatedAnnual report
「No new business or other risks arose during the six-month period ended [the second quarter]. There were also no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The company disclosed that there had been no material changes regarding the risks of medical device defects, voluntary recalls and medical accidents. - FY2020-Q1RestatedAnnual report
「No new business or other risks arose during the three-month period ended [the first quarter]. There were also no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The company disclosed that there had been no material changes regarding the risks of medical device defects, voluntary recalls and medical accidents. - FY2019RestatedAnnual report
「If a medical accident occurs as a result of a product defect, or if there are concerns that a medical accident may occur, we may take measures such as suspending sales or recalling the product.」
The company continued to describe the possibility of medical device defects, sales suspensions, recalls and lawsuits seeking damages, and reiterated quality-control measures to mitigate these risks. - FY2019-Q3RestatedAnnual report
「No new business or other risks arose during the cumulative third quarter of the current consolidated fiscal year. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The company disclosed that there had been no material changes regarding the risks of medical device defects, voluntary recalls and medical accidents. - FY2018RestatedAnnual report
「If a medical accident occurs as a result of a product defect, or if there are concerns that a medical accident may occur, we may take measures such as suspending sales or recalling the product. In addition, if a medical accident occurs as a result of a product defect or other problem, we may face lawsuits seeking damages or other claims.」
The company continued to provide specific details on the possibility that medical device defects could lead to sales suspensions, recalls or lawsuits seeking damages. - FY2018-Q3RestatedAnnual report
「No new business or other risks arose during the cumulative third quarter of the current consolidated fiscal year. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The company disclosed that there had been no material changes regarding the risks of medical device defects, voluntary recalls and medical accidents. - FY2018-Q1RestatedAnnual report
「No new business or other risks arose during the three-month period ended [the first quarter]. There were also no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The company disclosed that there had been no material changes regarding the risks of medical device defects, voluntary recalls and medical accidents. - FY2017WorsenedAnnual report
「If a medical accident occurs as a result of a product defect, or if there are concerns that a medical accident may occur, we may take measures such as suspending sales or recalling the product. In addition, if a medical accident occurs as a result of a product defect or other problem, we may face lawsuits seeking damages or other claims.」
The company provided specific details on the potential impact if defects lead to sales suspensions, recalls or lawsuits seeking damages, in addition to the possibility of defects occurring. - FY2017-Q3RestatedAnnual report
「No new business or other risks arose during the cumulative third quarter of the current consolidated fiscal year. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The risks of medical device defects, voluntary recalls and medical accidents were treated as having undergone no material changes. - FY2017-Q2RestatedAnnual report
「No new business or other risks arose during the six-month period ended [the second quarter]. There were also no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The risks of medical device defects, voluntary recalls and medical accidents were treated as having undergone no material changes. - FY2017-Q1RestatedAnnual report
「No new business or other risks arose during the three-month period ended [the first quarter]. There were also no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The company disclosed that there had been no material changes regarding the risks of medical device defects, voluntary recalls and medical accidents. - FY2016First statedAnnual report
「Because our group handles medical devices directly related to patients’ lives, we strictly manage the quality of products manufactured in-house and products procured domestically and overseas, although we cannot completely rule out the possibility of defects or other problems.」
While describing the risk of defects as a general possibility, the company recorded a ¥60 million loss on disposal in the current fiscal year in connection with the voluntary recall of certain products.